- Home
- LICY vs MNOV Comparison
LICY vs MNOV Comparison
Compare LICY & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICY
- MNOV
- Stock Information
- Founded
- LICY 2016
- MNOV 2000
- Country
- LICY Canada
- MNOV United States
- Employees
- LICY N/A
- MNOV N/A
- Industry
- LICY Environmental Services
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- LICY Industrials
- MNOV Health Care
- Exchange
- LICY Nasdaq
- MNOV Nasdaq
- Market Cap
- LICY 83.8M
- MNOV 87.3M
- IPO Year
- LICY N/A
- MNOV 2005
- Fundamental
- Price
- LICY $2.41
- MNOV $1.86
- Analyst Decision
- LICY Hold
- MNOV
- Analyst Count
- LICY 3
- MNOV 0
- Target Price
- LICY $5.36
- MNOV N/A
- AVG Volume (30 Days)
- LICY 2.3M
- MNOV 133.9K
- Earning Date
- LICY 11-07-2024
- MNOV 11-22-2024
- Dividend Yield
- LICY N/A
- MNOV N/A
- EPS Growth
- LICY N/A
- MNOV N/A
- EPS
- LICY N/A
- MNOV N/A
- Revenue
- LICY $27,400,000.00
- MNOV $1,000,000.00
- Revenue This Year
- LICY $48.13
- MNOV N/A
- Revenue Next Year
- LICY $18.15
- MNOV N/A
- P/E Ratio
- LICY N/A
- MNOV N/A
- Revenue Growth
- LICY N/A
- MNOV N/A
- 52 Week Low
- LICY $1.22
- MNOV $1.12
- 52 Week High
- LICY $15.36
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- LICY 46.18
- MNOV 57.75
- Support Level
- LICY $2.69
- MNOV $1.49
- Resistance Level
- LICY $4.98
- MNOV $2.55
- Average True Range (ATR)
- LICY 0.57
- MNOV 0.17
- MACD
- LICY -0.04
- MNOV 0.05
- Stochastic Oscillator
- LICY 13.60
- MNOV 50.00
About LICY Li-Cycle Holdings Corp.
Li-Cycle Holdings Corp is a lithium-ion battery resource recovery and lithium-ion battery recycler. The company's proprietary process Spoke and Hub recycling process is designed at its Spokes, to process battery manufacturing scrap and end-of-life batteries to produce black mass and other intermediate products, and at its Hubs, to process black mass to recover raw materials, including but not limited to lithium carbonate, cobalt sulphate, and nickel sulphate.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.